$ Value
$0
Shares
61,963
Price
$0
Filed
Feb 13
Insider
Name
Stevens Christopher James
Title
Chief Operating Officer
CIK
0002079768
Roles
Transaction Details
Transaction Date
2026-02-11
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
469,129
Footnotes
Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. | Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years. | This option represents a right to purchase a total of 93,037 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.
Filing Info
Stevens Christopher James's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | RCKT | A | $0 |
| 2026-02-11 | RCKT | A | $0 |
| 2025-08-04 | RCKT | A | $0 |
| 2025-08-04 | RCKT | A | $0 |
Other Insiders at RCKT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Militello John
See Remarks
|
— | $16K | 2026-02-18 |
|
Wilson Martin
General Counsel
|
— | $45K | 2026-02-18 |
|
Shah Gaurav
CEO
|
— | $61K | 2026-02-18 |
|
Rizvi Syed Ali-aamir
Chief Medical Officer
|
— | — | 2026-02-11 |
|
Chaudhuri Sarbani
See Remarks
|
— | — | 2026-02-11 |
|
Stevens Christopher James
Chief Operating Officer
|
— | — | 2026-02-11 |